Matches in Wikidata for { <http://www.wikidata.org/entity/Q59616701> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- Q59616701 description "article scientifique (publié 2009)" @default.
- Q59616701 description "artikull shkencor i botuar më 01 janar 2009" @default.
- Q59616701 description "artículu científicu espublizáu en xineru de 2009" @default.
- Q59616701 description "im Januar 2009 veröffentlichter wissenschaftlicher Artikel" @default.
- Q59616701 description "scientific article published on 01 January 2009" @default.
- Q59616701 description "wetenschappelijk artikel" @default.
- Q59616701 description "наукова стаття, опублікована в січні 2009" @default.
- Q59616701 name "Nonpegylated Liposomal Doxorubicin (TLC-D99), Paclitaxel, and Trastuzumab in HER-2-Overexpressing Breast Cancer: A Multicenter Phase I/II Study" @default.
- Q59616701 name "Nonpegylated Liposomal Doxorubicin (TLC-D99), Paclitaxel, and Trastuzumab in HER-2-Overexpressing Breast Cancer: A Multicenter Phase I/II Study" @default.
- Q59616701 name "Nonpegylated Liposomal Doxorubicin (TLC-D99), Paclitaxel, and Trastuzumab in HER-2-Overexpressing Breast Cancer: A Multicenter Phase I/II Study" @default.
- Q59616701 type Item @default.
- Q59616701 label "Nonpegylated Liposomal Doxorubicin (TLC-D99), Paclitaxel, and Trastuzumab in HER-2-Overexpressing Breast Cancer: A Multicenter Phase I/II Study" @default.
- Q59616701 label "Nonpegylated Liposomal Doxorubicin (TLC-D99), Paclitaxel, and Trastuzumab in HER-2-Overexpressing Breast Cancer: A Multicenter Phase I/II Study" @default.
- Q59616701 label "Nonpegylated Liposomal Doxorubicin (TLC-D99), Paclitaxel, and Trastuzumab in HER-2-Overexpressing Breast Cancer: A Multicenter Phase I/II Study" @default.
- Q59616701 prefLabel "Nonpegylated Liposomal Doxorubicin (TLC-D99), Paclitaxel, and Trastuzumab in HER-2-Overexpressing Breast Cancer: A Multicenter Phase I/II Study" @default.
- Q59616701 prefLabel "Nonpegylated Liposomal Doxorubicin (TLC-D99), Paclitaxel, and Trastuzumab in HER-2-Overexpressing Breast Cancer: A Multicenter Phase I/II Study" @default.
- Q59616701 prefLabel "Nonpegylated Liposomal Doxorubicin (TLC-D99), Paclitaxel, and Trastuzumab in HER-2-Overexpressing Breast Cancer: A Multicenter Phase I/II Study" @default.
- Q59616701 P1433 Q59616701-3023F57F-307F-444B-BC76-F4ABD43DFA0D @default.
- Q59616701 P1476 Q59616701-56C45E00-82D4-4660-A340-B0B9EC73E26B @default.
- Q59616701 P2093 Q59616701-10EA9E89-D55E-4F95-8C46-BB336DEF9137 @default.
- Q59616701 P2093 Q59616701-136AACCF-DC66-403A-8A3E-EB9DFE0F0EF4 @default.
- Q59616701 P2093 Q59616701-1E3E7387-797E-4D53-8B7F-7DF902485E65 @default.
- Q59616701 P2093 Q59616701-1EF99F60-AD26-4A8C-ABB0-3E37B9C2FAF4 @default.
- Q59616701 P2093 Q59616701-29CE88B7-BBAD-4B5C-94A7-9C6E8CFCA976 @default.
- Q59616701 P2093 Q59616701-3CCD1CEA-551E-4909-8624-E3336CFC942C @default.
- Q59616701 P2093 Q59616701-814E2D20-61DC-4DEC-B893-F49DEDB39C53 @default.
- Q59616701 P2093 Q59616701-9810FD45-29F6-4BFC-8D1A-EBEE87B53602 @default.
- Q59616701 P2093 Q59616701-AD6D51AE-3656-4176-ADF6-01B68ADCAE60 @default.
- Q59616701 P2093 Q59616701-AFF89AB9-63E3-4A8B-8455-94DA14226364 @default.
- Q59616701 P2093 Q59616701-D451D38F-4DCD-4FA2-954E-B887126B0BE6 @default.
- Q59616701 P2093 Q59616701-D863A654-D9DF-43E6-BA9D-414B4DEBC7B1 @default.
- Q59616701 P2093 Q59616701-E4EBDCC5-68FA-4AEF-A0A4-FF6F173A5DD9 @default.
- Q59616701 P2093 Q59616701-F867238B-9311-4A78-986B-6DF74D0A25B4 @default.
- Q59616701 P2093 Q59616701-F8B4A5CC-44A7-4F2C-BDAA-EB47450643C7 @default.
- Q59616701 P304 Q59616701-3B35F149-FF8F-4837-93A0-4F5C5FE55A54 @default.
- Q59616701 P31 Q59616701-D38E4166-618F-44F9-AF08-DCA8EEC45BED @default.
- Q59616701 P356 Q59616701-9A9960B7-D84A-4DC8-9D92-5B252DFA4BEB @default.
- Q59616701 P407 Q59616701-6C132779-8B04-4183-9655-AE24B1A8493A @default.
- Q59616701 P433 Q59616701-2B1FDD99-450E-4D0F-9A44-284C6239E47C @default.
- Q59616701 P478 Q59616701-D23B350E-841A-4F8A-8FB9-0DD5E0FA7E14 @default.
- Q59616701 P50 Q59616701-2C04744B-A0C1-4759-89C1-CD3A8D9E16D1 @default.
- Q59616701 P50 Q59616701-64EAA11E-CA7F-49FB-97F3-519C7CBE3E2F @default.
- Q59616701 P50 Q59616701-77DDE2B5-0428-4A36-B427-02E33E7728F1 @default.
- Q59616701 P577 Q59616701-7D2AAC7A-FCB8-4427-8822-83AD06706E57 @default.
- Q59616701 P698 Q59616701-BF5BF3A8-CDA7-4775-B46E-6CBB1E97A449 @default.
- Q59616701 P921 Q59616701-00F3F5E5-9D80-4F75-ADDF-24D21C63DB4F @default.
- Q59616701 P921 Q59616701-2252E173-65A1-4726-BC28-AF1732F537F0 @default.
- Q59616701 P921 Q59616701-84EEF664-226B-4CC6-B3E8-E26CBA5129F8 @default.
- Q59616701 P921 Q59616701-E2A39163-832F-4C07-9F69-215E6941B3B3 @default.
- Q59616701 P921 Q59616701-FDE6DEAC-80BC-48AE-B8A8-4F21E89C2F61 @default.
- Q59616701 P356 1078-0432.CCR-08-1113 @default.
- Q59616701 P698 19118059 @default.
- Q59616701 P1433 Q332253 @default.
- Q59616701 P1476 "Nonpegylated liposomal doxorubicin (TLC-D99), paclitaxel, and trastuzumab in HER-2-overexpressing breast cancer: a multicenter phase I/II study" @default.
- Q59616701 P2093 "Belén Ojeda" @default.
- Q59616701 P2093 "César A Rodríguez" @default.
- Q59616701 P2093 "Hernán Cortés-Funes" @default.
- Q59616701 P2093 "Josep Vazquez" @default.
- Q59616701 P2093 "José Baselga" @default.
- Q59616701 P2093 "José I Mayordomo" @default.
- Q59616701 P2093 "José M Trigo" @default.
- Q59616701 P2093 "Juan F Dorado" @default.
- Q59616701 P2093 "Lluís Cirera" @default.
- Q59616701 P2093 "Manuel Benavides" @default.
- Q59616701 P2093 "Miguel A Climent" @default.
- Q59616701 P2093 "Miguel Gil" @default.
- Q59616701 P2093 "Pere Gascón" @default.
- Q59616701 P2093 "Pilar Regueiro" @default.
- Q59616701 P2093 "Spanish Breast Cancer Cooperative Group SOLTI" @default.
- Q59616701 P304 "307-314" @default.
- Q59616701 P31 Q13442814 @default.
- Q59616701 P356 "10.1158/1078-0432.CCR-08-1113" @default.
- Q59616701 P407 Q1860 @default.
- Q59616701 P433 "1" @default.
- Q59616701 P478 "15" @default.
- Q59616701 P50 Q38643165 @default.
- Q59616701 P50 Q43114235 @default.
- Q59616701 P50 Q67755317 @default.
- Q59616701 P577 "2009-01-01T00:00:00Z" @default.
- Q59616701 P698 "19118059" @default.
- Q59616701 P921 Q128581 @default.
- Q59616701 P921 Q18936 @default.
- Q59616701 P921 Q412616 @default.
- Q59616701 P921 Q423762 @default.
- Q59616701 P921 Q61643320 @default.